Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis [PDF]
Journal of Rheumatology, 2017 Pamela F. Weiss +7 more
openalex +2 more sources
Use of healthcare administrative claims data in observational studies of antirheumatic drug effects on pregnancy outcomes: A scoping review. [PDF]
PLoS ONEThe safety of antirheumatic drugs in pregnancy and their impact on maternal and neonatal outcomes are understudied. Despite pregnant individuals being excluded from clinical trials, their continued use of medications raises the importance of addressing ...
Shenthuraan Tharmarajah +7 more
doaj +2 more sources
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis [PDF]
Arthritis care & research, 2012 Jasvinder A. Singh +29 more
openalex +2 more sources
153 Do Hydroxychloroquine, Disease-Modifying Antirheumatic Agents or Steroids, Serve to Prevent COVID-19 Infection? [PDF]
Ann Emerg Med, 2020 Daniel C. Keyes +4 more
europepmc +3 more sources
4. Antirheumatic Agents for Treatment of Rheumatoid Arthritis
Nihon Naika Gakkai Zasshi, 2008 Hisashi Yamanaka
openalex +4 more sources
Medication Persistence of Disease-Modifying Antirheumatic Drugs and Anti-Tumor Necrosis Factor Agents in a Cohort of Patients With Rheumatoid Arthritis in Brazil [PDF]
Arthritis care & research, 2016 Francisco de Assis Acúrcio +7 more
openalex +2 more sources
The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis. [PDF]
Arthritis & Rheumatism, 1990 Harold E. Paulus
semanticscholar +4 more sources
Effects of Abatacept in patients with rheumatoid arthritis and cancer risk [PDF]
Reviews in Clinical Medicine, 2023 Introduction: As a chronic autoimmune disease, Rheumatoid arthritis (RA) affects the joints. Studies have shown a complex and challenging link between cancer and RA.
Saba Homapoor +2 more
doaj +1 more source
Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis [PDF]
The Korean Journal of Internal Medicine, 2022 Background/Aims The aim of this study was to investigate long-term post-discontinuation outcomes in patients with rheumatoid arthritis (RA) who had been treated with tumor necrosis factor-α inhibitors (TNF-αi) which was then discontinued.
Kichul Shin +14 more
doaj +1 more source
Arthritis Research & Therapy, 2023 Background This study sought to evaluate the efficacy and safety of tofacitinib in patients with rheumatoid arthritis with distinct treatment histories. Methods Pooled phase II/III trial data from patients who received tofacitinib 5 or 10 mg twice daily ...
John Tesser +6 more
doaj +1 more source